MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*2022: 100 largest medtech companies
Haemonetics Corporation (NYSE:HAE)
Organization & Developments: Haemonetics
Parents
Haemonetics Corporation (NYSE:HAE)
Children
*Has established a position for its blood analyzer in the U.S. hospitals market.
*The diagnostics revenue figure is a 15.8 percent increase over fiscal 2010 diagnostics revenue.
$19 million coming from diagnostics products, comprised mostly of its Thromboelastograph Hemostasis Analyzer products.
2012: Acquisitions drive Haemonetics' Q2 earnings jump (2012)
2013: Haemonetics Corporation Closes Its Doors in MA (2013)
2014: Haemonetics loses Red Cross blood kit business worth $25M in revenue
2017: U.S. Army_MEDCOM_ANALYZER_Haemonetics
2017: VA_65--Haemonetics Cell Saver Elite System (Brand Name Only)
2018: U.S. Army_MEDCOM_Automated Cell Processor_HAEMONETICS
2018: VA_65--Haemonetics Brand TEG 6S Consumables (Reagents, Controls, Calibrators, and Disposables) for the TEG 6S Instrument.
2020: Haemonetics: Sustainable Growth Levers In Place, Above-Market Growth Opportunity
2021: Haemonetics Corp: Contrarian Flavour With Recent Market Punishment
2022: Haemonetics Leveraging Strong Recovery Trends And Repositioning For The Future_ seekingalpha.com
2022: Haemonetics: Plasma Thesis Continues To Play Out, Reiterate Buy_seekingalpha.com
2023: Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment (HAE)
2023: Haemonetics: Attracting Investment Through Capital Recycling Initiatives_seekingalpha.com
2023: Haemonetics: Solid Performance Of This Blood Play_seekingalpha.com
2024: Haemonetics Corporation: Improved Performance, Another Bolt-On Deal
2026: Haemonetics: Re-Rating Complete, Time To Cash In (NYSE:HAE)
Jumps
*Key People: Haemonetics
Finance & Acquisitions: Haemonetics